| Name | Title | Contact Details |
|---|
Chicago Heights is a city in Cook County, Illinois, United States.
interiors is a Mendocino, CA-based company in the Business Services sector.
CML Security, LLC is a prominent company specializing in security electronics integration and detention equipment installation. Founded in 1987 by Mike Langersmith, the company has evolved from its initial focus on detention equipment in the Western United States to a broader range of services, including security electronics installation, full system service, and preventative maintenance. Headquartered in Broomfield, Colorado, CML Security operates nationwide, including in Hawaii and Alaska. The company offers a variety of services tailored to different markets, such as correctional facilities, behavioral health centers, and courthouses. CML Security is recognized for its expertise in installing Security Wall Panel Systems and integrating IP Video Systems, HMI Interfaces, and PLC Controls. With a commitment to high-quality solutions and exceptional customer service, CML Security has built strong relationships with general contractors and architects, contributing to hundreds of projects across the country. The company has reported significant revenue, reflecting its robust operations and dedication to client satisfaction.
Medinitiatives is a Rancho Cordova, CA-based company in the Business Services sector.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.